Page last updated: 2024-08-18

pyrroles and Adenocarcinoma, Clear Cell

pyrroles has been researched along with Adenocarcinoma, Clear Cell in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (36.36)	29.6817
2010's	7 (63.64)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brady, W; Brown, J; Chan, JK; Gershenson, DM; Kim, JH; Monk, BJ; Rose, PG; Secord, AA; Shahin, MS; Walker, JL	1
Ferrero, S; Leone Roberti Maggiore, U; Valenzano Menada, M; Venturini, PL	1
Amaravadi, RK; Anglesio, MS; DeVorkin, L; Hattersley, M; Huntsman, DG; Kim, P; Levi, SM; Lum, JJ; Ries, J; Spowart, J; Tinker, AV; Winkler, JD	1
Andreadis, C; Kontovinis, LF; Kortsaris, AH; Mouratidou, D; Papazisis, KT; Touplikioti, P	1
Amraoui, S; Boulon, C; Conri, C; Constans, J; Solanilla, A; Viguier, JB	1
Bono, P; Joensuu, H; Rautiola, J; Utriainen, T	1
Anglesio, MS; Balkwill, F; Birrer, MJ; Bowtell, DD; Campbell, IG; Chakravarty, P; Coward, J; Cowin, PA; de Fazio, A; Friedlander, M; George, J; Gilks, CB; Gorringe, KL; House, CM; Huntsman, DG; Kalloger, SE; Kulbe, H; Lemech, C; Okamoto, A; Power, J; Rischin, D	1
Bansal, S; Kawsar, HI; Myles, JL	1
Cristofano, A; Malossi, A; Mozzicafreddo, A; Numico, G; Sicuro, M; Silvestris, N; Thiebat, B; Trogu, A	1
Fabbro, D; Funari, A; Kneissel, M; Longo, M; Migliaccio, S; Recchia, I; Rucci, N; Susa, M; Taranta, A; Teti, A	1
Tuma, RS	1

Reviews

1 review(s) available for pyrroles and Adenocarcinoma, Clear Cell

Article	Year
The potential of sunitinib as a therapy in ovarian cancer. Expert opinion on investigational drugs, 2013, Volume: 22, Issue:12 Topics: Adenocarcinoma, Clear Cell; Animals; Drug Approval; Drug Resistance, Neoplasm; Female; Humans; Indoles; Ovarian Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib	2013

Trials

3 trial(s) available for pyrroles and Adenocarcinoma, Clear Cell

Article	Year
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254). Gynecologic oncology, 2018, Volume: 150, Issue:2 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Ovarian Epithelial; Female; Humans; Indoles; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Pyrroles; Sunitinib; Young Adult	2018
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers. BMC cancer, 2009, Mar-12, Volume: 9 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Biomarkers, Tumor; Disease-Free Survival; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Platelet-Derived Growth Factor; Prognosis; Pyrroles; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2009
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-15, Volume: 17, Issue:8 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Angiogenesis Inhibitors; Cell Line, Tumor; Cluster Analysis; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Indoles; Interleukin-6; Middle Aged; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Pyrroles; Signal Transduction; STAT3 Transcription Factor; Sunitinib; Tissue Array Analysis; Treatment Outcome	2011

Other Studies

7 other study(ies) available for pyrroles and Adenocarcinoma, Clear Cell

Article	Year
Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma. Molecular cancer research : MCR, 2017, Volume: 15, Issue:3 Topics: Adenocarcinoma, Clear Cell; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Indoles; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyamines; Pyrroles; Sunitinib; Xenograft Model Antitumor Assays	2017
[An image of vena cava thrombosis]. Journal des maladies vasculaires, 2009, Volume: 34, Issue:5 Topics: Adenocarcinoma, Clear Cell; Aged, 80 and over; Angiogenesis Inhibitors; Fibrinolytic Agents; Heart Atria; Heparin, Low-Molecular-Weight; Humans; Image Processing, Computer-Assisted; Indoles; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Postoperative Complications; Pyrroles; Recurrence; Sunitinib; Thrombectomy; Tinzaparin; Tomography, X-Ray Computed; Vena Cava, Inferior; Venous Thrombosis	2009
Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Humans; Hypertension; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Pyrroles; Risk Factors; Sunitinib	2011
Acute renal failure: a rare side effect of sunitinib therapy. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:5 Topics: Acute Kidney Injury; Adenocarcinoma, Clear Cell; Aged; Antineoplastic Agents; Female; Humans; Indoles; Ovarian Neoplasms; Pyrroles; Sunitinib	2012
Takotsubo syndrome in a patient treated with sunitinib for renal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Aug-20, Volume: 30, Issue:24 Topics: Adenocarcinoma, Clear Cell; Female; Humans; Indoles; Kidney Neoplasms; Middle Aged; Pyrroles; Sunitinib; Takotsubo Cardiomyopathy	2012
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway. Bone, 2004, Volume: 34, Issue:1 Topics: Actins; Adenocarcinoma, Clear Cell; Animals; Apoptosis; Bone Resorption; Caspases; Cell Adhesion; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Osteoclasts; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Pyrroles; Rats; Rats, Wistar	2004
Three molecularly targeted drugs tested in kidney cancer clinical trials. Journal of the National Cancer Institute, 2004, Sep-01, Volume: 96, Issue:17 Topics: Adenocarcinoma, Clear Cell; Angiogenesis Inhibitors; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease-Free Survival; Enzyme Inhibitors; Humans; Indoles; Kidney Neoplasms; Phosphotransferases; Pyrroles; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Treatment Outcome	2004